Sterinova Uses Needle Protection Label with New Seal Function from Schreiner MediPharm
Needle-Trap Secu saves space and reduces waste, while being highly secured.
Aug 13, 2024
The security seal integrated in the needle protection system is automatically activated when pulling off the syringe cap and irreversibly indicates the first opening.
This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Key Takeaways:
Needle-Trap is said to be the only needle protection system worldwide whose needle trap is directly integrated into the label
The integrated seal function eliminates the need for an additional blister pack
The utilization of these heparin syringes with Needle-Trap Secu can reduce waste by 46% compared to conventional blister packs
Sterinova, a Canadian subsidiary of the medical technology company B. Braun, is a leading specialist in ready-to-use injectable drugs. The company has been successfully using Schreiner MediPharm’s proven Needle-Trap system for its prefilled heparin syringes since 2016. This solution provides effective protection against needlestick injuries while saving space and resources thanks to its compact design. Needle-Trap is said to be the only needle protection system worldwide whose needle trap is directly integrated into the label—an innovative combination enabling ease of use in daily healthcare settings while containing clearly less plastics compared to conventional needle protection systems.
The new variant, Needle-Trap Secu, additionally offers integrated first-opening indication: A special seal tab secures the integrity of the prefilled syringe until its used. Pulling off the syringe cap automatically activates the seal, which irreversibly indicates that the seal has been opened. The integrated seal function eliminates the need for an additional blister pack resulting in considerable space savings as well as reducing waste and cutting costs. In addition, special security elements prevent undetected reuse of the seal.
“We have been using Needle-Trap for nearly ten years because it allows us to perfectly combine needle protection and sustainability,” says Pierre Beaulieu, Vice President Sales and Marketing at Sterinova. “We are delighted to see that the new Needle-Trap Secu solution further enhances the positive properties, now also enabling us to offer our prefilled heparin syringes in loosely packaged form in a box because the integrity of each individual syringe is protected by the security seal.”
“According to our calculations, the utilization of our heparin syringes with Needle-Trap Secu can reduce waste by 46% compared to conventional blister packs,” says Pierre Beaulieu, Vice President Sales and Marketing from Sterinova. In addition, the compact Needle-Trap solution contributes to considerable reductions of CO2 emissions due to the reduction of waste at source, before the product is delivered to hospitals. This approach impacts positively the whole supply chain from the manufacturing site up to the waste destruction by hospitals. Moreover, the label-integrated needle trap consists of up to 50% re-granulated material, which further reduces the environmental footprint.
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
